Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois, U.S.A.
Auditing, Coding, Documentation and Compliance Consulting, Chehalis, Washington, U.S.A.
Arthroscopy. 2018 May;34(5):1730-1743. doi: 10.1016/j.arthro.2018.02.022. Epub 2018 Apr 12.
This article reviews the benefits of corticosteroid, viscosupplementation, platelet-rich plasma, and autologous mesenchymal stem cell injections for the treatment of patients with knee osteoarthritis. Integrating injections into both clinical and surgical practices is complicated given existing health insurance reimbursement policies. This review describes the outcomes associated with these interventions and appropriate methods of navigating the existing reimbursement pathways to help providers implement these treatments into their practices.
本文回顾了皮质类固醇、黏弹性补充剂、富含血小板的血浆和自体间充质干细胞注射治疗膝骨关节炎患者的益处。考虑到现有的健康保险报销政策，将注射纳入临床和手术实践是复杂的。本综述描述了这些干预措施相关的结果，并介绍了适当的方法来利用现有的报销途径，以帮助提供者将这些治疗方法应用于他们的实践中。
